No Data
No Data
Mayinglong Pharmaceutical Group Co., Ltd. (SHSE:600993) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mayinglong Pharmaceutical Group Co., Ltd. (SHSE:600993) shareholders have had their patience rewarded with a 26% share price jump in the last month. Looking further back, the 11% rise over the last
Ma Yinglong (600993.SH): Net profit of 198 million yuan in the first quarter increased 5.36% year over year
Gelonghui, April 19: Ma Yinglong (600993.SH) released its report for the first quarter of 2024. During the reporting period, it achieved operating income of 955 million yuan, an increase of 14.70%; net profit attributable to shareholders of listed companies was 198 million yuan, an increase of 5.36% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 193 million yuan, an increase of 35.67% year on year; and basic earnings per share were 0.46 yuan.
Mayinglong Pharmaceutical Receives Registration Approval for New Colorectal Treatment
Mayinglong Pharmaceutical Group (SHA:600993) has obtained a drug registration certificate from China's National Medical Products Administration to register its new colorectal treatment, according to a
Ma Yinglong (600993.SH): Compound polyethylene glycol electrolyte dispersion (III) obtained drug registration certificate
Gelonghui, April 16丨Ma Yinglong (600993.SH) announced that the company recently received the Compound Polyethylene Glycol Electrolyte Powder (III) (“the drug”) “Drug Registration Certificate” (certificate number: 2024S00546) approved and issued by the State Drug Administration. Compound polyethylene glycol electrolyte dispersion (III) is suitable for colonoscopy and removal of intestinal contents during colorectal surgery.
Estimating The Intrinsic Value Of Mayinglong Pharmaceutical Group Co., Ltd. (SHSE:600993)
Key Insights The projected fair value for Mayinglong Pharmaceutical Group is CN¥25.19 based on 2 Stage Free Cash Flow to Equity Mayinglong Pharmaceutical Group's CN¥25.77 share price indicates it is
Ma Yinglong (600993.SH): Net profit in 2023 fell 7.38% year on year, and plans to distribute 4 yuan for 10 shares
Gelonghui, April 12 | Ma Yinglong (600993.SH) released its 2023 annual report. Operating revenue was 3.137 billion yuan, down 11.20% year on year, net profit was 443 million yuan, down 7.38% year on year, after deducting non-net profit of 352 million yuan, down 23.61% year on year, with basic earnings of 1.03 yuan per share. A cash dividend of 4 yuan is distributed to all shareholders for every 10 shares.
No Data